Successful heart transplantation for COVID‐19‐associated post‐infectious fulminant myocarditis

Various clinical presentations of the 2019 coronavirus disease (COVID‐19) have been described, including post‐infectious acute and fulminant myocarditis. Here, we describe the case of a young patient admitted for COVID‐19‐associated post‐infectious fulminant myocarditis. Despite optimal pharmacologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaudriot, Baptiste, Mansour, Alexandre, Thibault, Vincent, Lederlin, Mathieu, Cauchois, Aurélie, Lelong, Bernard, Ross, James T., Leurent, Guillaume, Tadié, Jean‐Marc, Revest, Matthieu, Verhoye, Jean‐Philippe, Flecher, Erwan, Nesseler, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239812/
https://www.ncbi.nlm.nih.gov/pubmed/33934560
http://dx.doi.org/10.1002/ehf2.13326
Descripción
Sumario:Various clinical presentations of the 2019 coronavirus disease (COVID‐19) have been described, including post‐infectious acute and fulminant myocarditis. Here, we describe the case of a young patient admitted for COVID‐19‐associated post‐infectious fulminant myocarditis. Despite optimal pharmacologic management, haemodynamic status worsened requiring support by veno‐arterial extracorporeal membrane oxygenation. Emergent heart transplantation was required at Day 11 given the absence of cardiac function improvement. The diagnosis of post‐infectious COVID‐19‐associated myocarditis was made from both pathologic examination of the explanted heart and positive SARS‐CoV‐2 serology.

Ejemplares similares